Early control of viral load by favipiravir promotes survival to Ebola virus challenge and prevents cytokine storm in non-human primates.

• Päätekijät: Stéphanie Reynard (Tekijä), Emilie Gloaguen (Tekijä), Nicolas Baillet (Tekijä), Vincent Madelain (Tekijä), Jérémie Guedj (Tekijä), Hervé Raoul (Tekijä), Xavier de Lamballerie (Tekijä), Jimmy Mullaert (Tekijä), Sylvain Baize (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Public Library of Science (PLoS), 2021-03-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Ebola virus has been responsible for two major epidemics over the last several years and there has been a strong effort to find potential treatments that can improve the disease outcome. Antiviral favipiravir was thus tested on non-human primates infected with Ebola virus. Half of the treated animal...